Earnings History Data for GeoVax Labs, Inc. (GOVX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

GeoVax Labs, Inc.

GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
29-02-2024	AH		GOVX	GeoVax Labs, Inc.	4.20	N/A	-3.60	3.00	GeoVax GAAP EPS of -$14.29 beats by $0.26 [2/29/2024 6:14 PM]	2.54	-0.02 (-0.78%)	2.56	0.0 (0.00%)	2.04 - 11.85	32,558	60,000	2,595
GeoVax GAAP EPS of -$14.29 beats by $0.26 [2/29/2024 6:14 PM]
08-11-2023	PM		GOVX	GeoVax Labs, Inc.	14.10	-0.32	-0.17	-0.17	GeoVax GAAP EPS of -$0.32 misses by $0.11 [11/9/2023 9:51 AM]	0.53	-0.02 (-3.64%)	0.52	-0.03 (-4.56%)	0.47 - 1.39	86,396	130,000	4,008
GeoVax GAAP EPS of -$0.32 misses by $0.11 [11/9/2023 9:51 AM]
09-08-2023	AH		GOVX	GeoVax Labs, Inc.	14.73	-0.22	-0.16	-0.18	GeoVax GAAP EPS of -$0.22 misses by $0.05 [8/9/2023 5:37 PM]	0.5411	-0.02 (-2.89%)	0.56	0.0 (0.50%)	0.53 - 2.99	202,602	200,000	17,253
GeoVax GAAP EPS of -$0.22 misses by $0.05 [8/9/2023 5:37 PM]
04-05-2023	AH	4:00 PM ET (May 4)	GOVX	GeoVax Labs, Inc.	15.98	-0.15	-0.19	-0.34	GeoVax GAAP EPS of -$0.15 beats by $0.08 [5/4/2023 4:55 PM]	0.6237	-0.03 (-4.05%)	0.62	-0.03 (-4.25%)	0.53 - 4.30	213,716	230,000	7,059
GeoVax GAAP EPS of -$0.15 beats by $0.08 [5/4/2023 4:55 PM]
23-03-2023	AH	4:00 PM ET (Mar 23)	GOVX	GeoVax Labs, Inc.	20.31	-0.20	-0.17	-2.24	GeoVax GAAP EPS of -$0.83 misses by $0.03, revenue of $0.08M beats by $0.02M [3/23/2023 4:20 PM]	0.6802	0.02 (3.06%)	0.66	0.0 (-0.15%)	0.53 - 4.30	135,000	330,000	14,905
GeoVax GAAP EPS of -$0.83 misses by $0.03, revenue of $0.08M beats by $0.02M [3/23/2023 4:20 PM]
09-11-2022	AH	4:00 PM ET (Nov 9)	GOVX	GeoVax Labs, Inc.	21.82	-0.17	-0.12	-0.31	GeoVax GAAP EPS of -$0.17 [11/9/2022 5:01 PM]	0.7701	-0.01 (-0.68%)	0.76	-0.02 (-2.63%)	0.55 - 5.61	483,204	810,000	30,431
GeoVax GAAP EPS of -$0.17 [11/9/2022 5:01 PM] GeoVax Reports 2022 Third Quarter Financial Results and Provides Corporate Update [Nov-09-22 04:00PM]
03-08-2022	AH	5:00 PM ET (Aug 3)	GOVX	GeoVax Labs, Inc.	7.97	-0.18	0.00	-0.21	GeoVax GAAP EPS of -$0.18 [8/3/2022 5:09 PM]	3.48	0.74 (27.19%)	3.92	-0.40 (-9.26%)	0.55 - 7.50	75,276,391	100,130,000	51,552
GeoVax GAAP EPS of -$0.18 [8/3/2022 5:09 PM] GeoVax Reports 2022 Second Quarter Financial Results and Provides Corporate Update [Aug-03-22 04:00PM]
27-04-2022	AH	5:00 PM ET (Apr 27)	GOVX	GeoVax Labs, Inc.	6.09	-0.34	0.00	-0.29	GeoVax GAAP EPS of -$0.34 misses by $0.03, revenue of $0.08M [4/27/2022 5:39 PM]	0.8175	-0.21 (-20.63%)	0.86	-0.17 (-16.31%)	0.73 - 7.50	1,012,768	3,450,000	47,248
GeoVax GAAP EPS of -$0.34 misses by $0.03, revenue of $0.08M [4/27/2022 5:39 PM] GeoVax Labs Stock Jumps On US Patent For Malaria Vaccine Candidate [Apr-26-22 11:39AM] GeoVax Announces Issuance of Malaria Vaccine Patent [Apr-26-22 09:00AM] GeoVax Reports 2022 First Quarter Financial Results and Provides Corporate Update [Apr-27-22 04:00PM]
09-03-2022	AH	5:00 PM ET (Mar 9)	GOVX	GeoVax Labs, Inc.	10.00	-2.24	0.00	0.00		1.45	-0.10 (-6.42%)	1.59	0.04 (2.58%)	0.0 - 0.0	99,297	0	610
GeoVax reports FY results [3/9/2022 4:22 PM] GeoVax Reports 2021 Year-End Financial Results and Provides Corporate Update [Mar-09-22 04:00PM] Data Published in a Lancet Journal on COH04S1, a City of Hope-Developed COVID-19 Vaccine, Shows it Produced Robust Antibodies and T cells Against SARS-CoV-2 [Mar-10-22 09:00AM]
11-11-2021	AH	5:00 PM ET (Nov 11)	GOVX	GeoVax Labs, Inc.	26.51	-0.31	0.00	-0.73	GeoVax EPS beats by $0.06 [11/11/2021 4:10 PM]	3.88	0.03 (0.78%)	3.86	0.01 (0.26%)	2.56 - 8.71	83,753	270,000	1,695
GeoVax EPS beats by $0.06 [11/11/2021 4:10 PM] The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance [Nov-10-21 08:19AM] GeoVax Labs In-Licenses Development Rights To Multi-Antigenic COVID-19 Vaccine Candidate [Nov-10-21 06:58AM] GeoVax Reports 2021 Third Quarter Financial Results and Provides Corporate Update [Nov-11-21 04:00PM]
11-08-2021	AH	5:00 PM ET (Aug 11)	GOVX	GeoVax Labs, Inc.	28.73	-0.21	0.00	-0.60	GeoVax EPS beats by $0.22 [8/11/2021 4:26 PM]	4.09	-0.16 (-3.69%)	4.30	0.06 (1.30%)	2.56 - 12.60	425,672	600,000	5,455
GeoVax EPS beats by $0.22 [8/11/2021 4:26 PM] GeoVax Reports 2021 Second Quarter Financial Results and Provides Corporate Update [Aug-11-21 04:00PM] GeoVax to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 [Aug-12-21 09:00AM]
06-05-2021	AH	5:00 PM ET (May 6)	GOVX	GeoVax Labs, Inc.	38.97	-0.29	0.00	-2.60	GeoVax reports Q1 results [5/6/2021 4:38 PM]	5.95	-0.35 (-5.56%)	5.80	-0.50 (-7.94%)	2.56 - 35.00	490,277	640,000	18,244
GeoVax reports Q1 results [5/6/2021 4:38 PM] GeoVax to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 [May-06-21 11:30AM] GeoVax Reports 2021 First Quarter Financial Results and Provides Corporate Update [May-06-21 04:00PM]
05-11-2020	AH		GOVX	GeoVax Labs, Inc.	10.29	-0.73	0.00	-99.99	GeoVax reports Q3 results [11/5/2020 5:51 PM]	2.81	-0.09 (-3.10%)	2.85	-0.05 (-1.72%)	2.30 - 68.00	192,636	2,422,106	3,250